Pfizer three-dose COVID vaccine 80% effective against symptomatic omicron infection for youngest children
(NEW YORK) -- In long-awaited data, Pfizer said its 3-dose vaccine was 80% effective against symptomatic omicron COVID-19 infection among children 6 months to under 5 years old.The company cautioned that estimate was preliminary and could be adjusted as more data is collected. The...